Cargando…
Mesenchymal Stem Cells as Therapeutic Agents and Novel Carriers for the Delivery of Candidate Genes in Acute Kidney Injury
Acute kidney injury (AKI) is a heterogeneous syndrome characterized by a dramatic increase in serum creatinine. Mild AKI may merely be confined to kidney damage and resolve within days; however, severe AKI commonly involves extrarenal organ dysfunction and is associated with high mortality. There is...
Autores principales: | Liu, Yuxiang, Fang, Jingai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748887/ https://www.ncbi.nlm.nih.gov/pubmed/33381189 http://dx.doi.org/10.1155/2020/8875554 |
Ejemplares similares
-
The Beneficial Effects of Mesenchymal Stem Cells in Acute Kidney Injury: A Narrative Review
por: Liu, Yuxiang, et al.
Publicado: (2023) -
Cellular senescence, a novel therapeutic target for mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2020) -
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors
por: Xia, Xi, et al.
Publicado: (2011) -
Microparticles from Kidney-Derived Mesenchymal Stem Cells Act as Carriers of Proangiogenic Signals and Contribute to Recovery from Acute Kidney Injury
por: Choi, Hoon Young, et al.
Publicado: (2014) -
Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
por: Chulpanova, Daria S., et al.
Publicado: (2018)